1734 logo

Sinphar PharmaceuticalLtd Stock Price

Symbol: TWSE:1734Market Cap: NT$5.7bCategory: Pharmaceuticals & Biotech

1734 Share Price Performance

Community Fair Values

    Recent 1734 News & Updates

    No updates

    Sinphar Pharmaceutical Co.,Ltd. Key Details

    NT$3.2b

    Revenue

    NT$1.9b

    Cost of Revenue

    NT$1.3b

    Gross Profit

    NT$960.5m

    Other Expenses

    NT$306.7m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    1.69
    Gross Margin
    39.87%
    Net Profit Margin
    9.65%
    Debt/Equity Ratio
    49.3%

    Sinphar Pharmaceutical Co.,Ltd. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 1734

    Founded
    1977
    Employees
    n/a
    CEO
    Youyang Bai
    WebsiteView website
    www.sinphar.com.tw

    Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.

    Taiwanese Market Performance

    • 7 Days: 0.5%
    • 3 Months: 16.4%
    • 1 Year: 5.0%
    • Year to Date: 3.0%
    In the last week, the market has stayed flat, however the Energy sector stood out, gaining 8.6%. As for the longer term, the market has risen 5.0% in the past 12 months. As for the next few years, earnings are expected to grow by 13% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading